Literature DB >> 8381612

Angiotensin II enhancement of hormone-stimulated cAMP formation in cultured vascular smooth muscle cells.

S W Kubalak1, J G Webb.   

Abstract

The mechanism by which angiotensin II (ANG II) potentiates hormone-induced adenosine 3',5'-cyclic monophosphate (cAMP) formation was studied in cultured rat vascular smooth muscle cells. Incubation of cells for 60 s with 100 nM ANG II produced a two- to threefold enhancement of cAMP stimulation when coupled with isoproterenol, prostaglandin I2, or adenosine. ANG II also enhanced cAMP formation when adenylyl cyclase was stimulated directly with forskolin or activated through the stimulatory guanyl nucleotide-binding protein (Gs) with cholera toxin. Forskolin stimulation was increased by only 40%, but cholera toxin-stimulated cAMP formation was doubled. Activation of protein kinase C with phorbol 12-myristate 13-acetate (PMA) enhanced isoproterenol-stimulated cAMP by 51%, but inhibitors of protein kinase activation had little effect on ANG II enhancement of cAMP production. However, use of PMA to cause feedback inhibition of D-myo-inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] formation blocked the effect of ANG II on agonist-stimulated cAMP formation, and the time course for this effect of PMA paralleled its inhibitory effect on Ins(1,4,5)P3 production. Furthermore, chelation of intracellular Ca2+ or treatment with calmodulin antagonists also diminished the synergism between ANG II and isoproterenol for cAMP stimulation. The results indicate that ANG II enhances cAMP formation in vascular smooth muscle cells by facilitating the interaction between activated Gs and adenylyl cyclase. In addition, the data suggest that this effect of ANG II is directly related to Ins(1,4,5)P3 stimulation and appears to involve a Ca(2+)-calmodulin-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381612     DOI: 10.1152/ajpheart.1993.264.1.H86

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Identification of a cAMP-response element in the regulator of G-protein signaling-2 (RGS2) promoter as a key cis-regulatory element for RGS2 transcriptional regulation by angiotensin II in cultured vascular smooth muscles.

Authors:  Zhongwen Xie; Dexiang Liu; Shu Liu; Lindsay Calderon; Guogang Zhao; John Turk; Zhenheng Guo
Journal:  J Biol Chem       Date:  2011-11-04       Impact factor: 5.157

2.  Chronic in vivo angiotensin II administration differentially modulates the slow delayed rectifier channels in atrial and ventricular myocytes.

Authors:  Dimitar P Zankov; Fadi N Salloum; Min Jiang; Gea-Ny Tseng
Journal:  Heart Rhythm       Date:  2018-08-01       Impact factor: 6.343

3.  Angiotensin II-activated Ca2+ entry-induced release of Ca2+ from intracellular stores in rat portal vein myocytes.

Authors:  J L Morel; N Macrez-Leprêtre; J Mironneau
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

4.  Reciprocal roles of angiotensin II and Angiotensin II Receptors Blockade (ARB) in regulating Cbfa1/RANKL via cAMP signaling pathway: possible mechanism for hypertension-related osteoporosis and antagonistic effect of ARB on hypertension-related osteoporosis.

Authors:  Xiao-Xu Guan; Yi Zhou; Ji-Yao Li
Journal:  Int J Mol Sci       Date:  2011-06-27       Impact factor: 5.923

5.  Biochemical and molecular aspects of vascular adrenergic regulation of blood pressure in the elderly.

Authors:  William E Schutzer; Scott L Mader
Journal:  Int J Hypertens       Date:  2011-09-22       Impact factor: 2.420

6.  Determining the association between hypertension and bone metabolism markers in osteoporotic patients.

Authors:  Zhuoqing Hu; Kevin Yang; Zhihui Hu; Miaosheng Li; Hao Wei; Zheng Tang; Baitong Chen; Chengbiao Su; Jinrong Xu
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.